Radiopharma: Comeback of Nuclear Medicine in Oncology
Nuclear medicine never disappeared: it remained clinically relevant but strategically underdeveloped. For decades, its role was largely confined to diagnostics and a limited set of therapeutic indications. However, its underlying capability of delivering highly targeted ...read more
published on Oct 13, 2026